US Broker Ratings

Triller Group Inc. (ILLR) Stock Analysis: Navigating the Challenges in the Software Industry

Triller Group Inc. (ILLR), a name that resonates within the dynamic landscape of the technology sector, is currently navigating through a series of challenges that present both risks and opportunities..

Donnelley Financial Solutions (DFIN) Stock Analysis: Exploring a 9.29% Potential Upside

Donnelley Financial Solutions, Inc. (NYSE: DFIN) stands at the intersection of technology and finance, offering cutting-edge software and technology-enabled regulatory and compliance solutions. With its headquarters in Lancaster, Pennsylvania, DFIN..

Similarweb Ltd. (SMWB) Stock Analysis: Unlocking a 49.62% Potential Upside

For investors with a keen eye on the technology sector, Similarweb Ltd. (NASDAQ: SMWB) presents an intriguing prospect. With its roots in the digital analytics space, this Israel-based company is..

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: A Promising Biotech with 126% Upside Potential

CytomX Therapeutics, Inc. (NASDAQ: CTMX) is capturing investor attention with its significant upside potential of 126.34%, making it a compelling prospect in the biotechnology sector. With a market cap of..

Alpha Teknova, Inc. (TKNO) Stock Analysis: Exploring a Potential 96% Upside for Savvy Investors

Alpha Teknova, Inc. (NASDAQ: TKNO) has captured the attention of investors with its promising potential in the healthcare sector, specifically within the niche of drug manufacturers specializing in both specialty..

Tyler Technologies, Inc. (TYL) Stock Analysis: A Strong Buy with 19.43% Potential Upside

Tyler Technologies, Inc. (NYSE: TYL), a leader in the public sector software and technology solutions space, offers investors a compelling opportunity with a projected 19.43% potential upside. As the company..

A2Z Cust2Mate Solutions Corp. (AZ) Stock Analysis: Unpacking the 84.5% Potential Upside

A2Z Cust2Mate Solutions Corp. (AZ) is capturing attention in the investment community with its remarkable potential upside of 84.5% based on current market data. Operating within the Technology sector, specifically..

Paychex, Inc. (PAYX) Stock Analysis: Navigating Growth with a Strong Dividend Yield

Paychex, Inc. (NASDAQ: PAYX), a leader in human capital management solutions, stands at a compelling junction for investors seeking exposure to the Technology sector, specifically within the Software – Application..

Dayforce, Inc. (DAY) Stock Analysis: Exploring Growth Potential and Analyst Sentiment

Dayforce, Inc. (NASDAQ: DAY), a prominent player in the Technology sector, specializes in Software – Application, with a burgeoning focus on Human Capital Management (HCM) solutions. This Minneapolis-based company has..

Sapiens International (SPNS) Stock Analysis: Is There Value in the Current Price?

Sapiens International Corporation N.V. (NASDAQ: SPNS) stands as a prominent player in the technology sector, specifically in the Software – Application industry. Headquartered in Holon, Israel, Sapiens provides innovative software..

RingCentral, Inc. (RNG) Stock Analysis: Exploring a 22.91% Potential Upside in the Cloud Communications Market

RingCentral, Inc. (NYSE: RNG), a key player in the cloud communications space, attracts investor attention with a promising 22.91% potential upside, as indicated by its current stock analysis. Despite its..

Intapp, Inc. (INTA) Stock Analysis: Exploring a 52.65% Upside Potential

Intapp, Inc. (NASDAQ: INTA), a key player in the software application sector, is capturing attention with its robust growth prospects and a potential upside of 52.65%, as suggested by current..

Sprout Social, Inc (SPT) Stock Analysis: Unveiling a 39% Potential Upside Amidst Market Volatility

Sprout Social, Inc (NYSE: SPT), a key player in the technology sector, specifically within the Software – Application industry, has piqued investor interest with its robust social media management platform..

Alkami Technology, Inc. (ALKT) Investor Outlook: A 38.44% Upside Potential Shines Amid Robust Growth

Alkami Technology, Inc. (NASDAQ: ALKT) is catching the eye of investors with a notable potential upside of 38.44%, driven by its promising growth trajectory and a solid market position in..

ServiceTitan, Inc. (TTAN) Stock Analysis: Exploring a 7.02% Upside Potential Amidst Robust Revenue Growth

ServiceTitan, Inc. (TTAN), a prominent player in the technology sector, has garnered considerable attention for its innovative cloud-based software solutions tailored to a broad spectrum of service industries. With a..

iTeos Therapeutics, Inc. (ITOS) Stock Analysis: Insights into its 5.01% Potential Upside

Investors eyeing the biotechnology sector know the inherent volatility and potential for significant returns that come with it. iTeos Therapeutics, Inc. (NASDAQ: ITOS), a clinical-stage biopharmaceutical company, is making waves..

NICE Ltd (NICE) Stock Analysis: A 31% Potential Upside Amid Strong Analyst Ratings

NICE Ltd (NICE), a leading player in the Technology sector, particularly in the Software – Application industry, offers a compelling case for investors seeking growth opportunities. The Israel-based company is..

Quhuo Limited (QH) Stock Analysis: Navigating Challenges with Potential Opportunities in China’s Gig Economy

Investors with an eye on emerging markets may find Quhuo Limited (QH) an intriguing prospect in the expansive gig economy sector in China. Despite facing significant challenges, the company’s strategic..

Alarm.com Holdings, Inc. (ALRM): Investor Outlook with 20.93% Potential Upside

Alarm.com Holdings, Inc. (ALRM) remains a compelling figure in the technology sector, specifically within the software application industry. With a market capitalization of $2.77 billion, Alarm.com has carved a niche..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Exploring Growth Potential in Biotech with Notable Analyst Ratings

In the ever-evolving landscape of biotechnology, Fulcrum Therapeutics, Inc. (FULC) emerges as a notable player, captivating investor attention with its strategic focus on genetically defined diseases. As a clinical-stage biopharmaceutical..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds